This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
However, the DEA and FDA still consider CBD a drug regulated under the Schedule I classification. The DEA definition of a Schedule 1 substance is : Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse.
As of the time of this writing, the bill’s text is not available on Congress.gov but is provided by Marijuana Moment’s Kyle Jaeger, who wrote a great article on the bill. It was presented with bipartisan support but the legislative process can be unpredictable. Remember, federal agencies only exist because of federal lawmakers.
Note: South Dakota’s weed-legalization legislation is currently facing legal challenges, because no list in this article can be simple. New Mexico and Virginia have approved legislation, and will join this list later in 2021, on June 29 and July 1, respectively.). South Dakota*. Washington. Washington D.C. New Hampshire.
On July 14, 2021, Senators Chuck Schumer (D-NY), Ron Wyden (D-OR), and Cory Booker (D-NJ) released the discussion draft of historic federal cannabis legalization legislation, the Cannabis Administration and Opportunity Act (CAOA). While unlikely to pass in this Congress, the momentous legislation gives us a roadmap for how the U.S.
There are remaining concerns as to the state health department’s treatment policy towards these products as well. This model can be replicated across many states during the current state legislative sessions and provide much-needed clarity and certainty to regulators and the industry alike.
It is my hope that the Governor will not move forward with this legislation and will instead acknowledge that the many negative consequences far outweigh any potential positive revenue for the Commonwealth.”. As recent as 2016, the DEA has reviewed and determined that under its judgment marijuana should remain a Schedule I substance.”.
Then, a blog post circulated online, notifying the industry that Spain’s food and safety authority, AECOSAN, had updated its legislation to prohibit the sale and distribution of products containing CBD being sold as food supplements. Irrespective of where the directive came from, policy on CBD has changed.
New Jersey failed to pass legislation legalizing recreational marijuana. In October, Senator Mitch McConnell directed the DEA to figure out how to distinguish hemp from marijuana. Several northeastern states tried to coordinate their marijuana policies. See the hearing’s webpage , for the details.
In North Dakota, a state legislative committee recently voted to accept amendments that would change the state’s definition of THC. But my contacts at the American Herbal Products Association, as well as the DEA (Drug Enforcement Administration) and the American Western Hemp Professionals, and the U.S. View original article.
Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. By Paul Armentano. Authors Tracy Gallegos and Neville M.
In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. The now-finalized rules originate from a 2020 voter-approved initiative, subsequently approved by the governor and finally implemented by legislative panel. 16 In the Weeds article) from the U.S.
Her pro-pot policies would take shape in college during the ’90s and early 2000s. Fried remembers the debate, featuring a then- High Times editor and a DEA agent, marking the first substantive cannabis conversation during her time at school. . View original article. Florida’s Ongoing Cannabis Reform Efforts. This is medicine.
A timeline of Florida’s battle for solid ground has been outlined in depth throughout my previous articles. While the strong Florida medical marijuana Crusaders marched forward, the state itself and the legislators who comprise the Rear Battalion lost some footing. . Florida’s marijuana future is showing promise.
Much of it was driven by Germanys newly formed government keeping its quasi-legalization policy intact, even if adult-use trials remain uncertain. As I discussed in The Hidden Potential Winners of Marijuana Rescheduling: DEA-Registered Bulk Manufacturers , U.S. marijuana policy permits only marijuana for research purposes.
Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S. But the facts in Eric Gandelione’s revelatory article for Cannabis Business Executive speak for themselves: . Download : Cannabis Misinformation: What Does the DEA say about Marijuana?
Griffen’s article is just one of many parsing the language of the 2018 Farm Bill and a 2023 DEA letter on the topic. See also: “ THCA and the DEA: Rod Breaks Down the Latest News ” from Rod Kight, an another attorney prominent in the space. I would say: “Someone over at DEA wrote a letter last year indicating that it’s not.
This makes history by enacting the first piece of standalone federal cannabis reform legislation in U.S. The Drug Enforcement Administration (DEA) is now mandated to approve applications to be manufacturers of marijuana-derived, FDA-approved drugs under the bill. The law gives the U.S. The law gives the U.S.
Those of you beginning to pick up regulated cannabis clients might find this article a useful and interesting read. This article focuses on analyzing the guidance on this topic from the state boards of accountancy and Tax Court cases. As of October 21, 33 states and the District of Columbia have allowed the use of medical marijuana.
And the next step, for this critical legislation, is getting further input from stakeholder groups, which is essential to the legislation’s success. With this highly anticipated legislation now landing in Congress, the industry has begun offering its response. Watch the full press conference below.
And the next step, for this critical legislation, is getting further input from stakeholder groups, which is essential to the legislation’s success. With this highly anticipated legislation now landing in Congress, the industry has begun offering its response. Watch the full press conference below.
And the next step, for this critical legislation, is getting further input from stakeholder groups, which is essential to the legislation’s success. With this highly anticipated legislation now landing in Congress, the industry has begun offering its response. Watch the full press conference below.
It’s our legislative proposal to end the federal prohibition on marijuana and repair damage done by the War on Drugs. Drug policy reform advocates widely hailed the introduction of the bill, noting the historical significance of the Senate Majority Leader leading the charge to end prohibition. View Bruce Barcott’s articles.
Speakers will describe how the DEA has handled these granted exemptions, such as filing a permit to import sacrament from another country and bringing back sacrament and going through customs. The panel will also address the DEA’s guidelines for applying for an exemption, and the potential costs, risks, and rewards of going ‘above ground’.
This stems from the fact that despite the ongoing legalization of both recreational and medical marijuana at the state level, cannabis is still classified as a Schedule I substance by the DEA, along with substances such as heroin, cocaine, opioids and methamphetamine.
And the next step, for this critical legislation, is getting further input from stakeholder groups, which is essential to the legislation’s success. With this highly anticipated legislation now landing in Congress, the industry has begun offering its response. Watch the full press conference below.
A special legislative session in June 2017 passed Senate Bill 8A , the Medical Use of Marijuana Act , to implement rules for making medical marijuana available to Floridians. To learn more about telehealth appointments and CannaMD ‘s COVID-19 safety measures, see: Coronavirus Policies. In practice, however, it’s very ambiguous.
Colombia had approved legislation in 2016 that regulates the production, distribution, sale and export of seeds, topicals and other cannabis products, but had prohibited the export of dried cannabis flower up until now, fearing that such a move would allow for the flow of legal cannabis products into the black market. View original article.
This article was contributed by SC Labs, a Leafly Certified Labs partner. In response to the 2018 farm bill, the USDA and the DEA have weighed in with interim rules establishing a system for the production of massive amounts of hemp-derived CBD and other cannabinoids. View original article. Presented By. March 31, 2021.
And now that delta-8 THC , its trendy cousin, has been outlawed in some states across the country and flagged by the DEA , THC-O’s star may rise even faster. . THC-O didn’t appear on the DEA’s radar until nearly 30 years later. View Max Savage Levenson’s articles. View original article.
Both for production and efforts in the next legislative session to overcome this. The news that is attached I replicate below, and I include as well a couple of newsletters from the American Bar Association Cannabis Law & Policy Committee that I Chair. I have an article in there called “Bicycle Day.” ” shorturl.at/fyXZ3.
Sure, the SAFE Banking Act has a heck of a lot of sponsors in the House of Representatives — and more Republican support than you might imagine — but there is still no sign that Senate leadership, a crucial component to all of this bill passing business, is prepared to embrace any pot-related legislation.
They write… In this week’s edition: Plans to vote on cannabis banking legislation announced in both chambers of Congress, with predictions that House will pass the SAFE Act by the end of October. DEA increases the cannabis research quota. Battle heating up over Florida ballot initiative to legalize cannabis for adult use.
Senate Majority Leader Chuck Schumer told reporters on Wednesday that, “I support decriminalization at the federal level, and we’ll be introducing legislation with a few of my colleagues shortly.” Analysts said they fell again in March due to apprehension over a legislative process that appeared to be stalling. .
The following year, President Richard Nixon declared drug abuse public enemy number one, and in 1973, he formed the Drug Enforcement Administration (DEA). The DEA limits how much psilocybin can be produced annually, which drives up costs, and the agency imposes other unnecessary burdens on researchers. The first is legislative.
Similarly, in spite of dozens of states enacting legislation that allows for recreational or medicinal use of cannabis, it remains federally illegal to possess, produce, and sell under the Controlled Substances Act (“CSA”) as a schedule I substance. As Kate Robertson pointed out in her article, this appears to be what Bright Green has done.
President Trump proposed ending an existing policy that protects state medical marijuana programs from Justice Department interference as part of his fiscal year 2021 budget plan released on Monday. Trump’s last two budgets omitted the medical cannabis protections language, and President Obama similarly asked for the policy to be removed.
The Obama Administration signed legislation late in 2016 that would expand the number of facilities growing marijuana for research, but the Drug Enforcement Agency hasn’t granted any licenses four years later. Furthermore, both NIDA and DEA have split oversight responsibilities of federally licensed marijuana spanning back several decades.
Cory Gardner (R) of Colorado and Elizabeth Warren (D) of Massachusetts, that would allow states to write their own marijuana policies, remove marijuana from the list in the CSA, and decriminalize it federally. That is the federal policy.” Joe’s latest policy stances on marijuana. Legalize medical marijuana.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content